Table 1.

Clinical characteristics of AHH men at baseline and follow up

Patient number	Baseline						Follow up
	Age at baseline (yr)	BMI (kg/m2)	Presenting symptoms	Pubertal history	Previous paternity	Comorbid conditions	Age at follow up (yr)	BMI (kg/m2)	Comorbid conditions	Interim medications (yr)
1	48	22.4	Impotence	Delayed	Yes		52	22.9		TDT (4)
2	32	24.4	Impotence and infertility	Normal	No		36	23.1		GnRH (4)
3a	40	35.2	Infertility	Normal	No	Hypertension and obesity	48	35.4	Hypertension and obesity	GnRH (8)
4a	48	22.6	Infertility and loss of libido	Delayed	No		56	22.5		hCG (8)
5a	57	27.9	Loss of libido	Normal	Yes	Depression	66	29.2	Depression	GnRH (0.5), hCG (1.5), TE (3), TDT (4)
6	37	24.1	Loss of libido and impotence	Normal	Yes		46	26.0		hCG (2), TE (1)
7a	37	24.3	Loss of libido	Normal	Yes	Previous history of depression	48	25.7	Migraines	hCG (0.5), TDT (7.5)
8a	41	28.4	Loss of libido	Normal	Yes		53	32.5	Type 2 diabetes	GnRH (12)
9a	28	21.8	Infertility	Delayed	Yes		47	25.2		GnRH (2), hCG (2), TE (4), TDT (11)
10a	29	28.4	Infertility	Normal	No		51	27.9		GnRH (2), hCG (9), TDT (11)

^aBaseline evaluation was reported previously (5). 

TE, Testosterone enanthate injections; TDT, transdermal testosterone (patch or gel); hCG, human chorionic gonadotropin; GnRH, pulsatile GnRH.